CANCER GENOMICS & PROTEOMICS (CGP) welcomes the submission of high quality original articles and reviews on all aspects ofthe application of genomic and proteomic technologies to experimental and clinical cancer research. The journal’s scientificspectrum includes: (a) molecular causes of carcinogenesis, cancer progression and metastasis; (b) structural and functionalaspects of genes in the cancer cell; (c) advances in genomic and proteomic technologies applicable to cancer research; (d)rational anticancer drug design and drug development. CGP will also accept abstracts and proceedings of scientific meetingsfor publication, following consideration and approval by the Editorial Board.
The principal aim of CGP is to provide for the prompt online publication of original works of high quality, generally within1-2 months of final acceptance.